touchpodcast

touchPODCAST

Science EN ↓ 546 episodes

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...

Author

touchpodcast

Category

Science

Podcast website

touchpodcast.podbean.com

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Focus on cognitive impairment in the diagnosis and management of relapsing MS – Part 3 15.03.2022

touchMDT for touchNEUROLOGY Listen to experts with multidisciplinary perspectives share their expert insights on the impact of cognitive dysfunction in relapsing MS, and how to best assess and manage the associated cognitive symptoms. The multidisciplinary team Neurologist/MS specialist: Prof. Mark Freedman, Canada Clinical psychologist/MS educator: Dr Rosalind Kalb, USA Neuropsychologist: Prof. D...

Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 2 15.03.2022

touchMDT for touchNEUROLOGY Listen to experts with multidisciplinary perspectives discuss the current treatment landscape for relapsing MS and how oral DMTs can improve patient outcomes. The multidisciplinary team Neurologist/MS specialist: Prof. Mark Freedman, Canada Clinical psychologist/MS educator: Dr Rosalind Kalb, USA Advanced practice clinician: Ms Amy Perrin Ross, USA This touchPODCAST is...

Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 1 15.03.2022

touchMDT for touchNEUROLOGY Listen to experts with multidisciplinary perspectives, discuss the importance of early diagnosis of relapsing MS for improved long-term patient outcomes. The multidisciplinary team Neurologist/MS specialist: Prof. Mark Freedman, Canada Clinical psychologist/MS educator: Dr Rosalind Kalb, USA This touchPODCAST is for HCPs only.  This activity is funded by an unrestricted...

MDT and patient perspectives on the importance of treatment intensification, weight loss, and education in T2D and obesity 11.03.2022

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss the benefits of early treatment intensification and weight loss for patients with T2D and obesity as well as the importance of effective patient education strategies.  The multidisciplinary team and patient Diabetes care & education specialist: Ms Jennifer Okemah, Kirkland, WA Endocrinologist...

MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity 11.03.2022

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development The multidisciplinary team and patient Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA Endocrinol...

MDT perspectives on the role of incretin hormones in wellness and in T2D 11.03.2022

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the role of incretin hormones in healthy individuals and in those with T2D and share insights from the latest research in this field  The multidisciplinary team Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA This touchPODCAST is for H...

Targeting the pathobiology of ESCC: Potential impact of immunotherapy on clinical practice 09.03.2022

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies. The experts Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Dr Jean-Phillippe Metges, Brest University Hospital, Brest, France Dr Radka Obermannova, Masaryk Memorial Cancer Institute Brno, C...

The evolving role of antibody–drug conjugates in the treatment of urothelial carcinoma 31.01.2022

Listen to a genitourinary cancer expert outline the use of antibody–drug conjugates in the treatment of urothelial carcinoma, including their place in current treatment guidelines, clinical trial data and the management of possible adverse events. The expert Dr Cora Sternberg, Weill Cornell Medicine, New York, NY, USA This touchPODCAST is for HCPs only.  This activity is funded by an unrestricted...

MDT and patient perspectives on the long-term management of patients with severe type 2 asthma 26.01.2022

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma.  The multidisciplinary team  Pulmonologist: Professor Alberto Papi, Italy Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Patient: Ms Jo...

MDT and patient perspectives on the disease burden of severe asthma 26.01.2022

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Allergist: Professor Ioana Agache, Romania Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This a...

MDT perspectives on biologic treatment selection in severe type 2 asthm 26.01.2022

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma. The multidisciplinary team  Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor Alberto Papi, Italy This touchPODCAST is for...

MDT and patient perspectives on the disease burden of severe asthma 26.01.2022

touchMDT for touchRESPIRATORY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families. The multidisciplinary team Primary care physician: Professor Barbara Yawn, USA Allergist: Professor Ioana Agache, Romania Patient: Ms JoJo O’Neal, USA This touchPODCAST is for HCPs only. This...

MDT perspectives on biologic treatment selection in severe type 2 asthma 26.01.2022

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma. The multidisciplinary team  Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Pulmonologist: Professor Alberto Papi, Italy This touchPODCAST is for H...

Advancing the treatment of MDS and AML: An update from ASH 2021 24.01.2022

touchCONGRESS for touchONCOLOGY Listen to Prof. Pierre Fenaux (France) review key data presented at ASH 2021 on emerging treatments for patients with higher-risk MDS and newly diagnosed AML and offer his insights on their potential impact on future clinical practice, alongside those from Dr Esther Oliva (Italy) and Prof. Andrew Wei (Australia). OVERVIEW Data review with Prof. Fenaux (0:00) Expert...

Immunotherapy for recurrent or metastatic head and neck squamous cell carcinoma 24.01.2022

touchPANEL DISCUSSION for touchONCOLOGY Listen to three experts as they explore key clinical considerations when using immune checkpoint inhibitors to treat recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The discussion includes the current role of immune checkpoint inhibitors, factors that may inform treatment decisions and approaches for managing side effects associated wi...

HPV infection and TGF-β: Translating the science into treatments for HPV-associated cancers 20.01.2022

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts consider the current treatment options and unmet needs for patients with HPV-associated cancers, the link between HPV and TGF-β, and how this is driving the development of new treatments. The experts Dr Judith Michels, Institut Gustave Roussy, Villejuif, France Dr Andrew Sikora, MD Anderson Cancer Center, Houston, TX, USA Dr Krishnan...

MDT and patient perspectives on the long-term management of patients with severe type 2 asthma 14.01.2022

touchMDT for touchIMMUNOLOGY Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma.  The multidisciplinary team  Pulmonologist: Professor Alberto Papi, Italy Allergist: Professor Ioana Agache, Romania Primary care physician: Professor Barbara Yawn, USA Patient: Ms JoJ...

Immune checkpoint inhibitors in prostate cancer: Current and future practice 13.01.2022

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts consider the current role of immune checkpoint inhibitors in prostate cancer and possible future directions. The experts Prof. Karim Fizazi - Gustave Roussy, Villejuif, France Dr Sandy Srinivas - Stanford University, Stanford, CA, USA Prof. Johann de Bono - The Institute of Cancer Research, London, UK This touchPODCAST is for HCPs on...

Targeting the pathobiology of ESCC: Potential impact of immunotherapy on clinical practice 06.12.2021

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies. The experts Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan Dr Jean-Phillipe Metges, University Hospital of Brest, Brest, France  This touchPODCAST is for HCPs only. This activity is funded...

Experts discuss how endotyping and biomarkers can help to guide treatment selection in severe type 2 asthma - touchIMMUNOLOGY 03.12.2021

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma. The experts Dr Katharine Woessner, Scripps Clinic Medical Group, San Die...

Experts discuss how endotyping and biomarkers can help to guide treatment selection in severe type 2 asthma - touchRESPIRATORY 03.12.2021

touchPANEL DISCUSSION for touchRESPIRATORY Listen to leading experts discuss the serious consequences of severe type 2 asthma, how endotyping and biomarkers can help guide treatment selection in such patients, and how recent data and clinical guidelines can inform the long-term management of patients with severe type 2 asthma. The experts Dr Katharine Woessner, Scripps Clinic Medical Group, San Di...

Improving outcomes for patients with NTM-LD 30.11.2021

touchEXPERT OPINIONS for touchINFECTIOUS DISEASES Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines. The experts Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA Dr Doreen Addrizzo-Harris, NYU Grossman School of Medicine, New York, NY, USA Dr Kevin Win...

Improving outcomes for patients with NTM-LD 30.11.2021

touchEXPERT OPINIONS for touchRESPIRATORY Listen to leading experts consider how to optimize the diagnosis of nontuberculous mycobacterial lung disease (NTM-LD) and how to manage it considering the latest treatment guidelines. The experts Dr Juzar Ali, LSU Health Sciences Center, New Orleans, LA, USA Dr Doreen Addrizzo-Harris, NYU Grossman School of Medicine, New York, NY, USA Dr Kevin Winthrop, O...

Achieving sustained outcomes for moderate-to-severe atopic dermatitis 30.11.2021

touchTALKS for touchIMMUNOLOGY This touchPODCAST is presented by Dr Melinda Gooderham, SKiN Centre for Dermatology, Peterborough, Ontario, Canada. Listen to Dr Gooderham present the latest data and future directions of systemic therapy for moderate-to-severe atopic dermatitis and how effective treatment can achieve sustained control of symptoms and improve the quality of life of patients and their...

Perspectives on the latest clinical data for targeted therapies for thyroid cancer 30.11.2021

touchMDT for touchONCOLOLOGY Listen to key experts from a multidisciplinary team discuss the latest efficacy and safety data for targeted therapies for thyroid cancer   The multidisciplinary team  Endocrinologist: Dr Antonio Matrone, Italy Nurse specialist: Ms Tara Hurley, UK Oncologist: Dr Lori Wirth, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent m...

Listen to the touchPODCAST podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.